Incidence, Predictors, and Clinical Outcomes of New-Onset Diabetes Mellitus after Percutaneous Coronary Intervention with Drug-Eluting Stent

about

Incidence, Predictors, and Clinical Outcomes of New-Onset Diabetes Mellitus after Percutaneous Coronary Intervention with Drug-Eluting Stent

Item

http://www.wikidata.org/entity/Q41648962

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Incidence, Predictors, and Cli ...... ention with Drug-Eluting Stent

@en

type

Item

label

Incidence, Predictors, and Cli ...... ention with Drug-Eluting Stent

@en

prefLabel

Incidence, Predictors, and Cli ...... ention with Drug-Eluting Stent

@en

P1476

Incidence, Predictors, and Cli ...... ention with Drug-Eluting Stent

@en

P2093

Byeong Keuk Kim

http://www.w3.org/2001/XMLSchema#string

Dong Ho Shin

http://www.w3.org/2001/XMLSchema#string

Donghoon Choi

http://www.w3.org/2001/XMLSchema#string

Eui Im

http://www.w3.org/2001/XMLSchema#string

Jung Sun Kim

http://www.w3.org/2001/XMLSchema#string

Kyeong Hyeon Chun

http://www.w3.org/2001/XMLSchema#string

Myeong Ki Hong

http://www.w3.org/2001/XMLSchema#string

Yangsoo Jang

http://www.w3.org/2001/XMLSchema#string

Young Guk Ko

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

Management of coronary artery disease: therapeutic options in patients with diabetes.

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.

P304

1603-1609

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3346/JKMS.2017.32.10.1603

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28875603

http://www.w3.org/2001/XMLSchema#string

P932

5592173

http://www.w3.org/2001/XMLSchema#string